Hepatitis C virus infection—prognosis and treatment

References

1. Seeff LB, Buskell-Bales Z, Wright EC. et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327:1906–1911
   [Google Scholar]
2. Kryger P, Christoffersen P, Aldershvile J. et al. The long-term prognosis of non-transfusion-associated non-A, non-B hepatitis. Scand J Gastroenterol 1983; 18:519–527
   [Google Scholar]
3. Hopf U, Möller B, Küther D. et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10:69–76
   [Google Scholar]
4. Esteban JI, López-Talavera JC, Genescà J. et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Int Med 1991; 115:443–449
   [Google Scholar]
5. Brillianti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet 1993; 341:464–465
   [Google Scholar]
6. Davis GL, Balart LA, Schiff ER. et al. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized controlled trial. N Engl J Med 1989; 321:1501–1506
   [Google Scholar]
7. Hepatology 1992 vol 16: no. 2 part 2. Abstracts of AASLD meeting
8. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16:865–876
   [Google Scholar]
9. Martin P, Munoz SJ, Di Bisceglie AM. et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 1991; 13:719–721
   [Google Scholar]